VitalHub - President and CEO, Dan Matlow
President and CEO, Dan Matlow
Source: Small Cap Power
  • VitalHub (VHI) will commence trading on the Toronto Stock Exchange on September 23 under the symbol VHI
  • The company’s common shares will be delisted from the TSXV 
  • Vitalhub Corporation is a Canadian company that develops technology solutions for health and human services providers
  • VitalHub (VHI) is currently up 1.38 per cent, trading at $2.94 per share

VitalHub (VHI) begins trading on the Toronto Stock Exchange on September 23, 2021.

This comes after the company received regulatory approval for the listing on August 30.

VitalHub’s common shares have been listed on the TSX Venture Exchange since December 2, 2016, under the symbol VHI. The company will list on the TSX under the same symbol. The company’s common shares will be delisted from the TSXV. 

Dan Matlow, CEO of VitalHub, commented,

“Uplisting to the TSX from the TSXV in five short years of trading is a great milestone for the company and further ratification of our progress to-date.”

“With over 400 customers spread across six countries internationally,” added Mr. Matlow, “the company is well-positioned for continued growth into the future.”

Vitalhub Corporation is a Canadian company that develops technology solutions for health and human services providers. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

The company serves health care providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors.

VitalHub (VHI) is currently up 1.38 per cent, trading at $2.94 per share as of 3:59 pm ET.

More From The Market Online

Siemens & Salesforce deepen AI partnership

Siemens (OTC Pink:SIEGY) and Salesforce (NYSE:CRM) expanded their AI partnership by integrating Agentforce with Teamcentre.

Cancer fighter Theralase aims to turn lab wins into human trials

Theralase (TSXV:TLT) begins Good Laboratory Practice toxicology analysis of Rutherrin, its drug candidate to target and destroy cancer cells.

System1 shares jump as MapQuest rides Lake Ontario drama to no. 1 app ranking

System1 stock (NYSE:SST) jumped 25% Thursday as MapQuest surged to the No. 1 navigation app in the U.S. following a spike in downloads.